{
  "description": null,
  "compose": {
    "include": [ {
      "system": "http://www.ama-assn.org/go/cpt",
      "concept": [ {
        "code": "1012415",
        "display": "Flow cytometry, interpretation"
      }, {
        "code": "3170F",
        "display": "Flow cytometry studies performed at time of diagnosis or prior to initiating treatment (HEM)"
      }, {
        "code": "88184",
        "display": "Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; first marker"
      }, {
        "code": "88185",
        "display": "Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; each additional marker (List separately in addition to code for first marker)"
      }, {
        "code": "88187",
        "display": "Flow cytometry, interpretation; 2 to 8 markers"
      }, {
        "code": "88189",
        "display": "Flow cytometry, interpretation; 16 or more markers"
      } ]
    } ]
  },
  "_filename": "ValueSet-2.16.840.1.113762.1.4.1116.508.json",
  "package_name": "us.nlm.vsac",
  "date": "2019-12-04T01:00:20-05:00",
  "meta": {
    "profile": [ "http://hl7.org/fhir/StructureDefinition/shareablevalueset", "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm" ],
    "versionId": "12",
    "lastUpdated": "2023-04-03T13:49:33.000-04:00"
  },
  "publisher": "CancerLinQ Steward",
  "jurisdiction": [ {
    "coding": [ {
      "code": "US",
      "system": "urn:iso:std:iso:3166"
    } ]
  } ],
  "purpose": "(Clinical Focus: ),(Data Element Scope: ),(Inclusion Criteria: ),(Exclusion Criteria: )",
  "name": "FlowCytometryStudiesPerformed",
  "type": null,
  "experimental": "false",
  "resourceType": "ValueSet",
  "expansion": {
    "total": 6,
    "contains": [ {
      "code": "1012415",
      "system": "http://www.ama-assn.org/go/cpt",
      "display": "Flow cytometry, interpretation",
      "version": "2024"
    }, {
      "code": "3170F",
      "system": "http://www.ama-assn.org/go/cpt",
      "display": "Baseline flow cytometry studies performed at time of diagnosis or prior to initiating treatment (HEM)",
      "version": "2024"
    }, {
      "code": "88184",
      "system": "http://www.ama-assn.org/go/cpt",
      "display": "Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; first marker",
      "version": "2024"
    }, {
      "code": "88185",
      "system": "http://www.ama-assn.org/go/cpt",
      "display": "Flow cytometry, cell surface, cytoplasmic, or nuclear marker, technical component only; each additional marker (List separately in addition to code for first marker)",
      "version": "2024"
    }, {
      "code": "88187",
      "system": "http://www.ama-assn.org/go/cpt",
      "display": "Flow cytometry, interpretation; 2 to 8 markers",
      "version": "2024"
    }, {
      "code": "88189",
      "system": "http://www.ama-assn.org/go/cpt",
      "display": "Flow cytometry, interpretation; 16 or more markers",
      "version": "2024"
    } ],
    "timestamp": "2023-11-15T07:20:36-05:00",
    "identifier": "urn:uuid:721d9f84-79a7-4999-a8e3-bde5a26843f7"
  },
  "title": "Flow Cytometry Studies Performed",
  "package_version": "0.15.0",
  "extension": [ {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-author",
    "valueString": "CancerLinQ Author"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
    "valueDate": "2022-12-15"
  }, {
    "url": "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
    "valueDate": "2023-04-03"
  } ],
  "status": "active",
  "id": "96252552-7315-4f95-9776-ee5a3a55e716",
  "kind": null,
  "url": "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113762.1.4.1116.508",
  "identifier": [ {
    "value": "urn:oid:2.16.840.1.113762.1.4.1116.508",
    "system": "urn:ietf:rfc:3986"
  } ],
  "version": "20191204"
}